Wells Fargo’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26 | Buy |
+2
| New | +$26 | ﹤0.01% | 6260 |
|
|
2024
Q2 | – | Sell |
-10
| Closed | -$176 | – | 6644 |
|
|
2024
Q1 | $176 | Hold |
10
| – | – | ﹤0.01% | 6129 |
|
|
2023
Q4 | $204 | Buy |
10
+1
| +11% | +$20 | ﹤0.01% | 6159 |
|
|
2023
Q3 | $156 | Buy |
9
+3
| +50% | +$52 | ﹤0.01% | 6266 |
|
|
2023
Q2 | $144 | Buy |
6
+1
| +20% | +$24 | ﹤0.01% | 6479 |
|
|
2023
Q1 | $133 | Hold |
5
| – | – | ﹤0.01% | 6552 |
|
|
2022
Q4 | $126 | Buy |
5
+1
| +25% | +$25 | ﹤0.01% | 6413 |
|
|
2022
Q3 | $0 | Buy |
4
+1
| +33% | – | ﹤0.01% | 6512 |
|
|
2022
Q2 | $0 | Sell |
3
-1,700
| -100% | – | ﹤0.01% | 6680 |
|
|
2022
Q1 | $62K | Buy |
1,703
+1,412
| +485% | +$51.4K | ﹤0.01% | 5220 |
|
|
2021
Q4 | $16K | Sell |
291
-208
| -42% | -$11.4K | ﹤0.01% | 5874 |
|
|
2021
Q3 | $36K | Sell |
499
-236
| -32% | -$17K | ﹤0.01% | 5430 |
|
|
2021
Q2 | $619K | Buy |
735
+732
| +24,400% | +$616K | ﹤0.01% | 4248 |
|
|
2021
Q1 | $2K | Sell |
3
-250
| -99% | -$167K | ﹤0.01% | 6262 |
|
|
2020
Q4 | $230K | Buy |
253
+251
| +12,550% | +$228K | ﹤0.01% | 4884 |
|
|
2020
Q3 | $3K | Buy |
2
+1
| +100% | +$1.5K | ﹤0.01% | 5743 |
|
|
2020
Q2 | $0 | Sell |
1
-93
| -99% | – | ﹤0.01% | 6009 |
|
|
2020
Q1 | $43K | Buy |
94
+20
| +27% | +$9.15K | ﹤0.01% | 5161 |
|
|
2019
Q4 | $15K | Sell |
74
-14
| -16% | -$2.84K | ﹤0.01% | 5495 |
|
|
2019
Q3 | $22K | Sell |
88
-55
| -38% | -$13.8K | ﹤0.01% | 5436 |
|
|
2019
Q2 | $359K | Buy |
143
+54
| +61% | +$136K | ﹤0.01% | 4473 |
|
|
2019
Q1 | $364K | Buy |
89
+5
| +6% | +$20.4K | ﹤0.01% | 4455 |
|
|
2018
Q4 | $259K | Buy |
84
+1
| +1% | +$3.08K | ﹤0.01% | 4596 |
|
|
2018
Q3 | $488K | Buy |
83
+1
| +1% | +$5.88K | ﹤0.01% | 4355 |
|
|
2018
Q2 | $288K | Sell |
82
-13
| -14% | -$45.7K | ﹤0.01% | 4685 |
|
|
2018
Q1 | $422K | Buy |
95
+10
| +12% | +$44.4K | ﹤0.01% | 4405 |
|
|
2017
Q4 | $325K | Buy |
85
+43
| +102% | +$164K | ﹤0.01% | 4558 |
|
|
2017
Q3 | $197K | Buy |
42
+1
| +2% | +$4.69K | ﹤0.01% | 4757 |
|
|
2017
Q2 | $183K | Buy |
+41
| New | +$183K | ﹤0.01% | 4671 |
|